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Endothelial Dysfunction and Increased Carotid Intima-Media 
Thickness in the Patients with Slow Coronary Flow
Flow mediated brachial dilatation (FMD) and carotid intima-media thickness (IMT) have 
been a surrogate for early atherosclerosis. Slow coronary flow in a normal coronary 
angiogram is not a rare condition, but its pathogenesis remains unclear. A total of 85 
patients with angina were evaluated of their brachial artery FMD, carotid IMT and 
conventional coronary angiography. Coronary flow was quantified using the corrected 
thrombosis in myocardial infarction (TIMI) frame count method. Group I was a control with 
normal coronary angiography (n = 41, 56.1 ± 8.0 yr) and group II was no significant 
coronary stenosis with slow flow (n = 44, 56.3 ± 10.0 yr). Diabetes was rare but 
dyslipidemia and family history were frequent in group II. Heart rate was higher in group II 
than in group I. White blood cells, especially monocytes and homocysteine were higher in 
group II. The FMD was significantly lower in group II than in group I. Elevated heart rate, 
dyslipidemia and low FMD were independently related with slow coronary flow in 
regression analysis. Therefore, endothelial dysfunction may be an earlier vascular 
phenomenon than increased carotid IMT in the patients with slow coronary flow.
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Cardiovascular Disorders
INTRODUCTION
Coronary slow flow is not a rare finding which characterized by 
angiographically normal or near-normal coronary arteries with 
delayed progression of the contrast agent into distal vasculature. 
It is characterized by slow velocity flow of dye through the coro-
nary artery in the absence of any evident obstructive lesion in it 
grossly. Since first description of this phenomenon in 1972, the 
mechanism of this phenomenon has not been extensively stud-
ied so far (1). On the basis of myocardial biopsy studies, it can 
be suggested that a combination of structural and functional 
obstruction exists in the coronary microcirculation (2, 3). 
  Previous studies have shown that impaired endothelial func-
tion plays an important role in this abnormal coronary vasore-
activity (4). Several surveys have investigated the relationship 
between coronary slow flow phenomenon and endothelial dys-
function as a probable etiology.
  Among several atherosclerotic surrogate, increased carotid 
intima-media thickness (IMT) was positively related with coro-
nary artery severity and cardiovascular event; therefore it regard-
ed as an early indicator of overall atherosclerosis (5). In the pres-
ent studies, the patients with obesity or ischemic heart disease 
proven coronary angiography were found to have increased 
IMT and impaired FMD compared to the healthy controls (6). 
However, the situation might not be same in patients with coro-
nary slow flow. Therefore, we aimed to determine the relation-
ship among the vascular risk factors, including endothelial dys-
function and carotid IMT in the patients with slow coronary flow.
MATERIALS AND METHODS
Study populations
The study population consisted of 150 patients with newly diag-
nosed stable angina. All of them were evaluated conventional 
coronary angiography, brachial artery FMD, and carotid IMT. 
We excluded subjects with significant narrowed coronary artery 
from coronary angiography (n = 65, 59.5 ± 8 yr). Eighty-five pa-
tients without significant coronary stenosis were divided into 
two groups according to the presence of coronary slow flow: 
Group I included patients without slow flow (n = 41, 56.1 ± 8.0 
yr) and group II patients with slow flow (n = 44, 56.3 ± 10.0 yr). 
We evaluated the relationship of the vascular risk factors, includ-Yoon HJ, et al.  •  Endothelial Dysfunction and Slow Coronary Flow
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ing endothelial dysfunction and carotid IMT in the patients with 
slow coronary flow.
Definition of slow coronary flow
Determination of frame counts was carried out by the method 
described previously by Gibson et al. (7). According to correct-
ed thrombolysis in myocardial infarction (TIMI) frame count, 
slow flow was defined as more than 2 standard deviations of 
frame count (TIMI 2) from the normal published range for that 
particular vessel (7). We corrected the TIMI frame count for the 
left anterior descending (LAD) to take account of the longer dis-
tance to the TIMI landmark. This ratio was obtained by dividing 
the mean TIMI frame count of the LAD by the mean TIMI frame 
count of the circumflex and the right coronary artery. More than 
two experienced cardiologists reviewed all the patients’ angiog-
raphy and calculated the frame count. Interobserver and intrao-
bserver agreement (κ-value) were 0.73 and 0.78 for TIMI flow 
grade respectively. Interobserver and intraobserver coefficients 
of variation were 9.72% and 5.86% for corrected TIMI frame 
count. Normal coronary artery was defined as no significant 
stenosis even at  < 50% of the diameter of the coronary artery.
Measurement of endothelial and vascular smooth muscle 
dysfunction
A Sequoia 512 ultrasound system (Siemens Corp, Upplands-
Väsby, Sweden) was used with a 15L8 transducer for brachial 
artery and a 8L5 transducer for carotid artery studies. All investi-
gations were digitally stored for analyses, which were performed 
by a single observer (EL, intraobserver variability r = 0.988) on 
a Sequoia 512. R-wave triggered end diastolic right brachial ar-
tery longitudinal images proximal to the antecubital fossa were 
recorded at baseline after 15 min of supine rest. Transducer po-
sition was carefully noted for subsequent investigations. For flow 
mediated dilatation (FMD), R-wave triggered images were stored 
for 90 sec following ischemia. The ischemia was induced using 
a cuff on the forearm inflated 20 mmHg above the systolic blood 
pressure for five minutes with additional lower arm muscular 
work by repetitively squeezing a small ball during the last min-
ute of ischemia. Maximal brachial artery diameter was calcu-
lated for both conditions as a mean of three measurements (8). 
After 15 min of recovery to the baseline diameter, 400 μg sublin-
gual nitroglycerine was administered and nitrogen mediated 
diameter (NMD) was assessed. FMD and NMD values were ex-
pressed as percentage change from baseline value. The repro-
ducibility of this method was reliable level in this study (r = 0.997, 
P < 0.001). 
Measurement of carotid artery intima-media thickness
Carotid artery studies were performed with the individual in 
the supine position with the neck extended and the chin turned 
away from the side being examined. The right and left common 
carotid artery proximal to the bulb was imaged in multiple lon-
gitudinal planes for the best resolution of the IMT of the far wall. 
The mean IMT was obtained manually tracing the intima-me-
dia in the far wall of the artery for a distance of approximately 
10 mm (9). Measurements were performed on three end dia-
stolic images and averaged.
Statistical analysis
All eligible patients enrolled in this study were included in the 
analysis. Standard statistics were used to describe the baseline 
clinical characteristics. Continuous variables are presented as 
mean ± standard deviations. Comparisons of means between 
the groups were done using a Student’s t-test and analysis of 
variance (ANOVA) as appropriate. A P value  < 0.05 was con-
sidered statistically significant. To find out optimal cutoff val-
ues, receiver operating characteristic (ROC) analysis was per-
formed. Sensitivity, specificity were calculated using typical for-
mulas. No missing value imputation was performed. All statisti-
cal analysis were performed with SPSS 15.0 for Windows (SPSS 
Inc., Chicago, IL, USA).
Ethics statement
The study protocol was reviewed and approved by the institu-
tional review board of Chonnam National University Hospital 
(No. 2010-05-092). All subjects provided their informed, written 
consent before participation.
RESULTS
Baseline characteristics
As shown in Table 1, there were no significant differences in age 
and gender between two groups. Baseline heart rate was higher 
in group II than in group I. Dyslipidemia and family history of 
premature cardiovascular disease were significantly frequent in 
Table 1. Baseline clinical characteristics
Parameters Group I (n = 41) Group II (n = 44) P value
Age (yr) 56.1 ± 8  56.3 ± 10 0.942
Sex (male, %) 20 (48.7) 22 (50.0) 0.433
Height (cm)   163.1 ± 9.8 162.8 ± 8.9 0.864
Weight (kg)      66.2 ± 11.8   67.0 ± 8.2 0.787
AC (cm)    86.43 ± 10.6     90.23 ± 10.65 0.166
BMI (kg/m
2)   25.06 ± 3.1 25.21 ± 3.5 0.849
Systolic BP (mmHg)  126.97 ± 14.2 126.64 ± 15.3 0.919
Diastolic BP (mmHg)      80.5 ± 11.6   80.16 ± 11.0 0.879
HR (/min)    66.1 ± 7.3   72.09 ± 6.26 0.001
Hypertension (%) 12 (29.3) 15 (34.0) 0.404
Diabetes (%)    9 (20.4) 2 (4.5) 0.018
Dyslipidemia (%)   5 (12.2) 21 (47.7) 0.001
Smoking (%) 11 (26.8) 15 (34.1) 0.312
Family history (%) 1 (2.4)   7 (17.0) 0.036
Data are given as mean ± SD or No. (%). AC, abdominal circumference; BMI, body 
mass index; BP, blood pressure; HR, heart rate.Yoon HJ, et al.  •  Endothelial Dysfunction and Slow Coronary Flow
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group II. The prevalence of diabetes was lower in groups II than 
in group I. The percentage of hypertension and smoking were 
not different between groups. 
Laboratory findings in the patients with coronary slow 
flow 
White blood cell count, especially monocytes was higher in 
group II than in group I. In spite of dyslipidemia was more fre-
quent in group II, the level of lipid profile contained total cho-
lesterol, low density lipoprotein (LDL) cholesterol, high density 
lipoprotein (HDL) and triglyceride was not significant different 
between groups. The level of homocysteine was higher in group 
II than in group I significantly. Other inflammatory marker such 
as high sensitivity C-reactive protein and fibrinogen were not 
significantly different between groups (Table 2).
The difference of endothelial and vascular smooth muscle 
function
The FMD showed normal distribution pattern; mean FMD was 
7.22 ± 3.62 (minimum 1.79% to maximum 21.43%). The FMD 
was significantly lower in group II than in group I (5.52 ± 2.18 vs 
9.03 ± 3.98, P < 0.001). NMD was not significantly different be-
tween two groups (Fig. 1). Avarage carotid IMT was 0.61 ± 0.15 
in the patients of this study. Carotid IMT was tended to be high-
er in group II, without no statistical significance (Table 3). 
The independent risk factors of slow coronary flow 
In regression analysis, elevated heart rate, dyslipidemia and low 
FMD were independently related with slow coronary flow in 
regression analysis (Table 4). The cut off value of FMD for pre-
Table 2. Laboratory findings in the patients with slow coronary flow
Laboratory parameters Group I (n = 41) Group II (n = 44) P value
WBC (/µL)   6,410 ± 1,705    7,536 ± 2,548 0.021
Monocytes (/µL)   430 ± 207    549 ± 200 0.010
Creatinine (mg/dL)   0.78 ± 0.24    0.81 ± 0.19 0.678
Total cholesterol (mg/dL) 159.60 ± 36.84  182.86 ± 39.29 0.128
LDL cholesterol (mg/dL) 131.22 ± 35.46  117.77 ± 38.10 0.097
HDL cholesterol (mg/dL)   52.69 ± 10.99    48.11 ± 14.31 0.104
Triglyceride (mg/dL) 100.63 ± 74.10 125. 78 ± 89.53 0.166
HbA1c (g/dL)   5.84 ± 0.85    5.88 ± 0.93 0.877
hs-CRP (mg/dL)   0.16 ± 0.18    0.57 ± 1.01 0.178
Homocysteine (µM/L)   7.34 ± 2.44    9.30 ± 4.89 0.031
Fibrinogen (µg/mL) 258.22 ± 59.12  277.49 ± 83.18 0.251
Data are given as mean ± SD. HDL, high density lipoprotein; hs-CRP, high-sensitivity 
C-reactive protein; WBC, white blood cells.
%
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Fig. 1. Differences of endothelial and vascular smooth muscular function. FMD, flow 
mediated dilatation; NMD, nitrogen mediated dilatation.
Fig. 2. Receiver operator characteristics curves of slow coronary flow. Arrow means 
cut off value of FMD (Area under the curve = 0.787, sensitivity = 0.773, specificity = 
0.732).
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Table 3. The difference of atherosclerotic surrogate in the patients with slow coro-
nary flow
Parameters Group I (n = 41) Group II (n = 44) P value
Pre FMD diameter (mm)   3.93 ± 0.67   4.09 ± 0.8 0.327
Post FMD diameter (mm)   4.27 ± 0.65     4.31 ± 0.81 0.783
FMD (%)   9.03 ± 3.93     5.52 ± 2.18 0.001
Pre NMD diameter (mm)   4.53 ± 0.27       4.12 ± 0.814 0.444
Post NMD diameter (mm)   4.69 ± 0.68     4.76 ± 0.81 0.660
NMD (%) 16.87 ± 18.4 16.37 ± 8.4 0.871
Left carotid IMT (mm)   0.55 ± 0.14     0.62 ± 0.17 0.095
Right carotid IMT (mm)   0.56 ± 0.13     0.60 ± 0.24 0.529
Data are given as mean ± SD. IMT, intima-media thickness; FMD, flow mediated   
dilatation; NMD, nitrogen mediated dilatation.
Table 4. Independent predictors of slow coronary flow
Predictors Hazard ratio Confidence interval P value
Heart rate ( > 70/min)   4.971 1.264-19.552 0.022
Dyslipidemia 13.050 1.739-97.910 0.012
Family history   5.229 0.091-302.080 0.424
WBCs    2.642 0.642-10.877 0.178
Monocytes   0.862 0.200-3.707 0.841
Homocysteine    1.468 0.370-5.830 0.585
FMD  17.228 3.006-98.774 0.001
CCA IMT, common carotid artery intima-media thickness; FMD, flow mediated dilata-
tion.Yoon HJ, et al.  •  Endothelial Dysfunction and Slow Coronary Flow
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diction of slow flow was 6.97% (area under the curve = 0.787, 
sensitivity = 77.3%, specificity = 73.2%) (Fig. 2).
DISCUSSION
Slow coronary flow means the slow dye progression into distal 
vasculature of coronary arteries during coronary angiography. 
It was reported in approximately 1% of patients undergoing con-
ventional coronary angiography (10). The exact mechanism was 
not clear until now; small vessel dysfunction may be involved 
in this phenomenon. Increased flow resistance, increased mi-
crovascular tone, platelet dysfunction (11), early demonstration 
of diffuse atherosclerosis (12), inflammation (13, 14), and an 
imbalance of vasoactive substances (15) have been suggested 
as underlying mechanisms. 
  In our study, baseline heart rate was higher in slow flow group 
and heart rate more than 70/min was the independent factor of 
slow flow. Increased sympathetic tone with elevated catechol-
amine levels may have direct effects on vessel or it may affect 
other factors promoting the progression of atherosclerosis. If 
we could measure the baseline catecholamine level, it would 
be more supportive presenting this phenomenon. This cate-
cholamine may be a role for the difference of family history in 
this study due to emotional stress. In spite of insignificance of 
the level of lipid profile, dyslipidemia was also significantly fre-
quent in slow flow group and an independent predictor of slow 
flow in this study. Fortunately, the patients with previous medi-
cated statin were excluded in this study, because they contained 
the group of significant coronary stenosis. Hyperlipidemia has 
been associated with an increased blood viscosity, which causes 
an increase in capillary resistance (16). Although diabetes was 
frequent risk factor of cardiovascular disease increasing inflam-
mation and vascular damage, diabetes was significantly more 
common in the control group than in slow flow group in this 
study. Because we analyzed the control and slow flow group  
after excluded the significant coronary artery lesion, it may be a 
result from analysis of the covariance for omission of the con-
founding factor. Vascular inflammatory marker was variety. In 
this study, we checked white blood cells with differential count, 
fibrinogen, hs-CRP and homocysteine. White blood cells, espe-
cially monocytes and homocysteine were elevated in the pa-
tient with slow flow. In a previous study, homocysteine levels 
increased but folate levels decreased in patients with slow coro-
nary flow (17). Even though we did not check the folate levels, 
the possible disturbance in the metabolism of homocysteine in 
patients with coronary slow flow may have a role in the patho-
genesis of this phenomenon associated with inflammation by 
causing generalized atherosclerosis. 
  Different theories have been postulated about the cause of 
small-vessel dysfunction, including microvascular tone altera-
tion, small-vessel wall thickening (18), patchy fibrosis and im-
paired endothelial release of nitric oxide (NO) (19, 20). The en-
dothelium plays a crucial role for initiation of atherosclerosis  
in early stage. Endothelial dysfunction was considered as early 
marker of atherosclerosis (21, 22). In this study, the FMD was 
significantly lower in slow flow group than in control and low 
FMD were independently related with slow coronary flow in 
regression analysis. The cut off value of FMD for prediction of 
slow flow was 6.97% from ROC curve. Vascular smooth muscle 
dysfunction from NMD was not affected in coronary slow flow. 
Collectively, it can be hypothesized that the impaired peripheral 
endothelial function (assessed by FMD of the brachial artery), 
not vascular smooth muscle, may also suggest the involvement 
of epicardial coronary arteries with slow flow. Another surro-
gate of early atherosclerosis is carotid IMT. Carotid arterial IMT 
correlates well with most cardiovascular risk factors and, in pop-
ulation studies, increasing carotid arterial wall thickness (IMT 
and plaques) has been associated with worsening coronary ar-
tery disease. Several studies have now demonstrated that carot-
id IMT is significantly increased in patients with slow coronary 
flow (23). However, our data showed carotid IMT was not sig-
nificantly different between normal and slow coronary flow pa-
tients. Since FMD constitutes a physiologic assessment of en-
dothelial dysfunction and carotid IMT is an anatomic structural 
measure of subclinical atherosclerosis, endothelial dysfunction 
is an earlier phenomenon than increased carotid IMT on the cas-
cade of atherosclerosis in the patients with slow coronary artery. 
  This study had several limitations. There was a patient selec-
tion bias. Because this study was cross-sectional, baseline char-
acteristics of this study could not be controlled, especially risk 
factors. Also, we did not consider about previous medication 
history. Although we measured FMD and carotid IMT in the 
state of holding drug during one day, previous duration of anti-
anginal or antiplatelets might affect the results of frame count 
in coronary angiography cession. There had insufficient impact 
for endothelial dysfunction due to absence of laboratory mark-
ers. Finally, our study population was relatively small, and fur-
ther large-scale clinical and experimental studies are warranted 
to detect precise pathogenesis and effective therapy for this sys-
temic disorder.
  Notwithstanding all these limitations, the data suggest that 
the slow coronary flow is not a simple, isolated change local-
ized in epicardial coronary arteries, but may be a part of sys-
temic vascular disturbance. 
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